Inflammation's Role in Reducing Motivation and Brain Circuit Changes in Schizophrenia
New research links inflammation to motivational deficits and brain circuit changes in schizophrenia, opening pathways for targeted treatments.
A recent study from Emory University has uncovered important insights into how inflammation relates to motivational deficits in individuals with schizophrenia. Published in the journal Neuropsychopharmacology, the research identified that elevated levels of C-reactive protein (CRP), a marker of inflammation produced by the liver, correlate with reduced activity in brain circuits responsible for reward and motivation. These brain alterations are specifically linked to negative symptoms observed in schizophrenia, such as difficulties in maintaining employment, relationships, or academic pursuits. Interestingly, inflammation levels did not show a connection to other symptoms like hallucinations, delusions, or depression.
The study focused on a key brain circuit involving the ventral striatum and ventromedial prefrontal cortex—areas known to be sensitive to inflammation in depression as well. Researchers found that higher CRP levels were associated with diminished functional connectivity within these reward-related regions, which likely contributes to motivational impairments.
This discovery is significant because current antipsychotic medications often fail to address these negative symptoms, which are strongly linked to poor functional outcomes in patients. By understanding the biological underpinnings involving inflammation, scientists are moving toward more targeted treatments. One promising approach is testing anti-inflammatory drugs like infliximab, commonly used for rheumatoid arthritis and inflammatory bowel disease, in clinical trials with schizophrenia patients exhibiting high inflammation and motivational challenges.
Dr. David Goldsmith from Emory emphasizes that this research advances the potential for precision medicine in schizophrenia, proposing that treatments addressing inflammation could offer relief specifically for patients with elevated inflammatory markers. Overall, these findings pave the way for innovative therapies aimed at improving motivation and daily functioning for individuals affected by schizophrenia.
Source: https://medicalxpress.com/news/2025-05-links-inflammation-brain-circuit-schizophrenia.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
New Research Shows Immune System's Role in Heart Attack-Related Arrhythmias
New research reveals that immune cells produce a protein that damages heart cells after a heart attack, leading to dangerous arrhythmias. Discover the potential for targeted therapies to prevent sudden cardiac death.
China Launches Nationwide Genomic Framework to Improve Rare Disease Diagnosis
A large-scale genomics study in China has established a new diagnostic framework for rare diseases, significantly improving detection rates and paving the way for better patient outcomes worldwide.
Innovative LED Hyperspectral Imaging System Promises Enhanced Cancer Detection During Endoscopy
A groundbreaking LED-based hyperspectral imaging system promises to enhance real-time cancer detection during endoscopy, potentially reducing missed tumors and improving diagnosis accuracy.
Germline Mismatch Repair Variants May Increase Risk of Uveal Melanoma
A recent study reveals that germline mutations in mismatch repair genes may predispose individuals to uveal melanoma, expanding our understanding of genetic risk factors associated with this eye cancer.